GlucoTrack【GCTK】銘柄情報

GlucoTrack Inc (GCTK) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.3883

( 1.65% )

買値

0.378

売値

0.40

出来高

293,820

0.3744 日の範囲 0.4199

0.2907 52 週間の範囲 15.90

時価総額

1.421M

前日終値

0.382

始値

0.3855

時刻

690

0.3883

(formt)

最終取引時間

財務取引量

US$ 117,692

VWAP

0.400559

平均取引量 (3 か月)

US$ 4,654,188

発行済株式数

3,659,279

配当利回り

PER

-0.04

1 株当たり利益 (EPS)

-17.13

歳入

純利益

-16.89M

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and i... GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

glucotrack.com

本社

Rutherford, United States

設立

2026

GlucoTrack Inc is listed in the Healthcare sector of the ナスダック市場 with ticker GCTK. The last closing price for GlucoTrack was US$0.38. Over the last year, GlucoTrack shares have traded in a share price range of US$ 0.2907 to US$ 15.90.

GlucoTrack currently has 3,659,279 shares in issue. The market capitalisation of GlucoTrack is US$1.42 million. GlucoTrack has a price to earnings ratio (PE ratio) of -0.04.

Form PRE 14A - Other preliminary proxy statements

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions

RUTHERFORD, N.J., May 26, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the...

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology

RUTHERFORD, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the...

Form 8-K - Current report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.06035	18.4021954566	0.32795	0.449	0.2907	2543114	0.40734366	CS
4	-0.0781	-16.7452830189	0.4664	0.73	0.2907	1093661	0.47303433	CS
12	-0.6717	-63.3679245283	1.06	1.67	0.2907	5326681	0.85874584	CS
26	-4.3917	-91.8765690377	4.78	4.96	0.2907	2657265	0.95735516	CS
52	-5.6817	-93.6029654036	6.07	15.9	0.2907	1880799	3.34466654	CS
156	-0.0237	-5.75242718447	0.412	15.9	0.0531	5020779	0.55342121	CS
260	-2.7717	-87.7120253165	3.16	15.9	0.0531	3693856	0.62840951	CS